BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19384079)

  • 1. Rab3B immunoexpression in human pituitary adenomas.
    Rotondo F; Scheithauer BW; Kovacs K; Bell DC
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):185-8. PubMed ID: 19384079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of SNAP-25 protein in adenomas of the human pituitary.
    Rotondo F; Kovacs K; Scheithauer BW; Horvath E; Bell CD; Lloyd RV; Cusimano M
    Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):477-81. PubMed ID: 18633321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Rab3, a Ras-related GTP-binding protein, in human nontumorous pituitaries and pituitary adenomas.
    Tahara S; Sanno N; Teramoto A; Osamura RY
    Mod Pathol; 1999 Jun; 12(6):627-34. PubMed ID: 10392640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
    Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.
    Vidal S; Kovacs K; Horvath E; Rotondo F; Kuroki T; Lloyd RV; Scheithauer BW
    Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph.
    Asa SL; Bamberger AM; Cao B; Wong M; Parker KL; Ezzat S
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2165-70. PubMed ID: 8964846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical localization of macrophage migration inhibitory factor in human hypophysis and pituitary adenomas.
    Tampanaru-Sarmesiu A; Stefaneanu L; Thapar K; Kovacs K; Donnelly T; Metz CN; Bucala R
    Arch Pathol Lab Med; 1997 Apr; 121(4):404-10. PubMed ID: 9140312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D2 receptor gene expression in human adenohypophysial adenomas.
    Stefaneanu L; Kovacs K; Horvath E; Buchfelder M; Fahlbusch R; Lancranjan L
    Endocrine; 2001 Apr; 14(3):329-36. PubMed ID: 11444429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ hybridization study of estrogen receptor messenger ribonucleic acid in human adenohypophysial cells and pituitary adenomas.
    Stefaneanu L; Kovacs K; Horvath E; Lloyd RV; Buchfelder M; Fahlbusch R; Smyth H
    J Clin Endocrinol Metab; 1994 Jan; 78(1):83-8. PubMed ID: 8288720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of von Hippel-Lindau protein (VHL-P) in nontumorous and adenomatous human pituitaries.
    Vidal S; Stefaneanu L; Kovacs K; Scheithauer BW
    Pituitary; 1999 May; 1(3-4):227-32. PubMed ID: 11081202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo responsiveness of morphological variants of growth hormone-producing pituitary adenomas to octreotide.
    Ezzat S; Kontogeorgos G; Redelmeier DA; Horvath E; Harris AG; Kovacs K
    Eur J Endocrinol; 1995 Dec; 133(6):686-90. PubMed ID: 8548053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of coexpression of somatostatin and dopamine D2 receptors in pituitary adenomas.
    Saveanu A; Jaquet P; Brue T; Barlier A
    Mol Cell Endocrinol; 2008 May; 286(1-2):206-13. PubMed ID: 18241980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human kallikrein 10 in surgically removed human pituitary adenomas.
    Rotondo F; Di Ieva A; Kovacs K; Cusimano MD; Syro LV; Diamandis EP; Yousef GM
    Hormones (Athens); 2015; 14(2):272-9. PubMed ID: 25553760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ghrelin immunoexpression in pituitary adenomas.
    Rotondo F; Cusimano M; Scheithauer BW; Rotondo A; Syro LV; Kovacs K
    Pituitary; 2011 Dec; 14(4):318-22. PubMed ID: 21340501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of vascular endothelial growth factor in growth hormone-secreting pituitary adenomas: special reference to the octreotide treatment.
    Kurosaki M; Saegert W; Abe T; Lüdecke DK
    Neurol Res; 2008 Jun; 30(5):518-22. PubMed ID: 18953743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell type-specific expression of the pituitary transcription activator pit-1 in the human pituitary and pituitary adenomas.
    Asa SL; Puy LA; Lew AM; Sundmark VC; Elsholtz HP
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1275-80. PubMed ID: 8077321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic and immunohistochemical characterization of spontaneous pituitary adenomas in fourteen cynomolgus macaques (Macaca fascicularis).
    Remick AK; Wood CE; Cann JA; Gee MK; Feiste EA; Kock ND; Cline JM
    Vet Pathol; 2006 Jul; 43(4):484-93. PubMed ID: 16846990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids.
    Alexander JM; Swearingen B; Tindall GT; Klibanski A
    J Clin Endocrinol Metab; 1995 Jan; 80(1):147-52. PubMed ID: 7829603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical hyperfunctioning pituitary adenomas: the silent tumors.
    Cooper O; Melmed S
    Best Pract Res Clin Endocrinol Metab; 2012 Aug; 26(4):447-60. PubMed ID: 22863387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress-response proteins in human pituitary adenomas. Expression of heat-shock protein 72 (HSP-72).
    Kontogeorgos G; Stefaneanu L; Kovacs K
    Endocrine; 1997 Feb; 6(1):25-9. PubMed ID: 9225112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.